These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 36656844

  • 1. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y, Amo-Antwi K, Hill PC, Dassah ET, Asmah RH, Nyarko KM, Agambire R, Konney TO, Yarney J, Damale N, Cox B.
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
    Debrah O, Agyemang-Yeboah F, Donkoh ET, Asmah RH.
    BMC Womens Health; 2021 Oct 26; 21(1):372. PubMed ID: 34702246
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET, Asmah RH, Agyemang-Yeboah F, Dabo EO, Wiredu EK.
    Cancer Control; 2022 Oct 26; 29():10732748221094721. PubMed ID: 35536890
    [Abstract] [Full Text] [Related]

  • 4. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T, Dube Mandishora R, Borok M.
    Intervirology; 2019 Oct 26; 62(2):90-95. PubMed ID: 31412350
    [Abstract] [Full Text] [Related]

  • 5. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leça L, Coimbra N, Tavares F, Baldaque I, Martins G, Monteiro P, Henrique R, Sousa H.
    J Med Virol; 2023 Jan 26; 95(1):e28414. PubMed ID: 36541747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Ruan Y, Li H, Liu M, Cao G, Xu X, Han L, Li F.
    Cancer Epidemiol; 2023 Jun 26; 84():102372. PubMed ID: 37119603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.
    Nagaraja M, Narendra H, Venkataramana B, Kalawat U.
    Indian J Med Microbiol; 2023 Jun 26; 43():73-78. PubMed ID: 36241529
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    Agyare Gyane F, Modey E, Maya E, Bonney EY, Abaidoo-Myles A, Paintsil E, Torpey K.
    PLoS One; 2024 Jun 26; 19(5):e0303535. PubMed ID: 38814956
    [Abstract] [Full Text] [Related]

  • 14. HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.
    Leite KRM, Pimenta R, Canavez J, Canavez F, de Souza FR, Vara L, Estivallet C, Camara-Lopes LH.
    Acta Cytol; 2020 Jun 26; 64(5):420-424. PubMed ID: 32235115
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    Egli-Gany D, Spaar Zographos A, Diebold J, Masserey Spicher V, Frey Tirri B, Heusser R, Dillner J, Petignat P, Sahli R, Low N, CIN3+plus study group.
    BMC Cancer; 2019 Jan 30; 19(1):111. PubMed ID: 30700274
    [Abstract] [Full Text] [Related]

  • 16. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
    Borena W, Grünberger M, Widschwendter A, Kraxner KH, Marth E, Mayr P, Meier J, Ruth N, Guerrero AT, Marth C, Holm-von Laer D.
    BMC Public Health; 2016 Aug 26; 16(1):889. PubMed ID: 27565569
    [Abstract] [Full Text] [Related]

  • 17. Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case-control study in Kumasi, Ghana.
    Yar DD, Salifu SP, Darko SN, Annan AA, Gyimah AA, Buabeng KO, Owusu-Dabo E.
    Trop Med Int Health; 2016 Feb 26; 21(2):275-82. PubMed ID: 26598430
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y, Effah K, Mawusi Wormenor C, Tekpor E, Aku Catherine Morkli E, Boafo E, Yorke E, Aryee R, Essel NOM, Danyo S, Kemawor S, Akpalu J.
    BMC Womens Health; 2024 Apr 25; 24(1):260. PubMed ID: 38664791
    [Abstract] [Full Text] [Related]

  • 19. Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.
    Zhang C, Cheng W, Liu Q, Guan Q, Zhang Q.
    Virol J; 2019 May 20; 16(1):67. PubMed ID: 31109361
    [Abstract] [Full Text] [Related]

  • 20. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Sousa H, Tavares A, Campos C, Marinho-Dias J, Brito M, Medeiros R, Baldaque I, Lobo C, Leça L, Monteiro P, Tavares F, Henrique R.
    Papillomavirus Res; 2019 Dec 20; 8():100179. PubMed ID: 31377173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.